INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV

Holdings History for Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL)

Symbol: AVDL on Nasdaq
Investment type: Equity / American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Jun 2024		-0.69%	$0	0	-87,375	-100%	$18.78	Q2 2024
31 Mar 2024	0.69%	-0.15%	$1,475,764	87,375	-19,100	-18%	$16.89	Q1 2024
31 Dec 2023	0.76%	+0.76%	$1,503,427	106,475	+106,475	NEW	$14.12	Q4 2023
30 Sep 2023		-0.8%	$0	0	-93,975	-100%	$18.78	Q3 2023
30 Jun 2023	0.8%	-0.31%	$1,548,708	93,975	-36,831	-28%	$16.48	Q2 2023
31 Mar 2023	0.64%	-0.04%	$1,198,183	130,806	-7,500	-5.4%	$9.16	Q1 2023
31 Dec 2022	0.52%	-0.01%	$990,271	138,306	-2,269	-1.6%	$7.16	Q4 2022
30 Sep 2022	0.37%	+0%	$704,000	140,575	+700	+0.5%	$5.01	Q3 2022
30 Jun 2022	0.18%	+0.06%	$341,000	139,875	+46,500	+50%	$2.44	Q2 2022
31 Mar 2022	0.32%	+0.02%	$638,000	93,375	+6,700	+7.7%	$6.83	Q1 2022
31 Dec 2021	0.33%	+0.06%	$700,000	86,675	+16,400	+23%	$8.08	Q4 2021
30 Sep 2021	0.36%	+0.04%	$689,000	70,275	+7,500	+12%	$9.80	Q3 2021
30 Jun 2021	0.23%	+0.03%	$422,000	62,775	+7,150	+13%	$6.72	Q2 2021
31 Mar 2021	0.29%	+0.29%	$503,000	55,625	+55,625	NEW	$9.04	Q1 2021
31 Dec 2020		-0.18%	$0	0	-53,325	-100%	$18.78	Q4 2020
30 Sep 2020	0.18%	+0.06%	$269,000	53,325	+17,125	+47%	$5.04	Q3 2020
30 Jun 2020	0.2%	+0.02%	$292,000	36,200	+3,600	+11%	$8.07	Q2 2020
31 Mar 2020	0.21%	-0.02%	$259,000	32,600	-3,500	-9.7%	$7.94	Q1 2020
31 Dec 2019	0.17%	0%	$273,000	36,100	0		$7.56	Q4 2019
30 Sep 2019	0.1%	+0.01%	$150,000	36,100	+3,000	+9.1%	$4.16	Q3 2019
30 Jun 2019	0.06%	-0%	$96,000	33,100	-1,650	-4.7%	$2.90	Q2 2019
31 Mar 2019	0.03%	+0%	$50,000	34,750	+500	+1.5%	$1.44	Q1 2019
31 Dec 2018	0.07%	+0%	$88,000	34,250	+2,000	+6.2%	$2.57	Q4 2018
30 Sep 2018	0.1%	+0.03%	$142,000	32,250	+8,800	+38%	$4.40	Q3 2018
30 Jun 2018	0.11%	+0.04%	$144,000	23,450	+8,400	+56%	$6.14	Q2 2018
31 Mar 2018	0.08%	+0.03%	$110,000	15,050	+4,700	+45%	$7.31	Q1 2018
31 Dec 2017	0.06%	-0%	$85,000	10,350	-700	-6.3%	$8.21	Q4 2017
30 Sep 2017	0.09%	0%	$116,000	11,050	0		$10.50	Q3 2017
30 Jun 2017	0.08%	0%	$122,000	11,050	0		$11.04	Q2 2017
31 Mar 2017	0.07%	+0.08%	$107,000	11,050	+11,050	NEW	$9.68	Q1 2017

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.